CDC, March 26, 2024 As of March 26, 2024, the SARS-CoV-2 Omicron variant JN.1 has very high prevalence in the United States, with CDC Nowcast projections estimating JN.1 to account for more than 95% of all COVID-19 illnesses in the US. The …
CDC updates and simplifies respiratory virus recommendations
CDC, March 1, 2024 CDC released today updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such …
Older adults now able to receive additional dose of updated COVID-19 vaccine
CDC, February 28, 2024 Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine dose. The recommendation acknowledges the increased risk …
CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season
Centers for Disease Control, September 12, 2023 CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna …
CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older
The CDC, October 19, 2022 Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults. This action gives people ages 18 years and older the option to receive a Novavax monovalent booster …